FIELD: chemistry.
SUBSTANCE: claimed invention relates to method of obtaining disodium salt of N-(5-chlorosaliciloyl)-8-aminocaprylic acid in form of monoethanolsolvate, octahydrate and monohydrate, as well as to method of obtaining mixture of disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid in form of mixture of two monohydrates.
EFFECT: obtaining novel forms of N-(5-chlorosalicyloyl)-8-aminocaprylic acid.
7 cl, 6 dwg, 6 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 5-CNAC AS AGENT FOR ORAL DELIVERY OF PARATHYROID HORMONE FRAGMENTS | 2002 |
|
RU2322256C2 |
| PHARMACEUTICAL COMPOSITION | 2006 |
|
RU2469709C2 |
| CALCITONIN USED AT OSTEOARTHRITIS | 2004 |
|
RU2368390C2 |
| ORAL ADMINISTRATION OF PARATHYROID HORMONE AND CALCITONIN | 2002 |
|
RU2300392C2 |
| PERORAL INTRODUCTION OF CALCITONIN | 2003 |
|
RU2355417C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING HGH FOR ORAL ADMINISTRATION | 2007 |
|
RU2493868C2 |
| PHARMACEUTICAL COMPOSITIONS FOR PERORAL INTAKE OF PHARMACOLOGICAL ACTIVE SUBSTANCES | 2001 |
|
RU2287999C2 |
| APPLICATION OF CALCITONIN FOR TREATING RHEUMATOID ARTHRITIS | 2006 |
|
RU2453330C2 |
| METHOD FOR SYNTHESIS OF N-SUBSTITUTED SALICYLAMIDES | 2005 |
|
RU2411234C2 |
| METHODS OF PULSING SYSTEMIC ADMINISTRATION OF PARATHYROID HORMONE ACTIVE FRAGMENT AND PHARMACEUTICAL COMPOSITIONS CONTAINING BIOLOGICALLY ACTIVE N-TERMINAL FRAGMENT OF PARATHYROID HORMONE | 1993 |
|
RU2142815C1 |
